19 May 2013
Keywords: biota, transfers, rsv, accord, astrazeneca, australian, drugmaker
Article | 01 September 2008
Australian drugmaker Biota says that its 2005 collaboration and license agreement with MedImmune has been assigned to the US firm's parent
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
8 September 2008
17 May 2013
© 2013 thepharmaletter.com